Brain+, a digital medicine company that focuses on addressing Alzhemer’s and dementia, has begun marketing an issue of units ahead of listing its shares on Nasdaq First North Growth Market Denmark. Each unit consists of one share and one warrant and is offered at Dkr5.69, corresponding to a pre-money valuation for Brain+ of Dkr40m. One…
Home Healthcare Markets International Business Denmark: Brain+ begins marketing of units to raise maximum gross proceeds of...